Bulldog Investors’s EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant EQHA.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-68,858
Closed -$689K 331
2021
Q3
$689K Sell
68,858
-1,142
-2% -$11.3K 0.2% 122
2021
Q2
$698K Hold
70,000
0.19% 121
2021
Q1
$694K Buy
+70,000
New +$710K 0.2% 112

Other funds holding EQHA.U

Bulldog Investors's EQHA.U Position: Q4 2021 in Review

Bulldog Investors sold out of EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (EQHA.U) in Q4 2021, closing a stake of 68,858 shares — an estimated $689K sold.

Bulldog Investors first reported a position in EQHA.U in Q1 2021 and held it in 3 quarters. The position peaked at $698K in Q2 2021. 23 funds tracked by Wall St. Rank hold EQHA.U as of Q4 2021.

  • Bulldog Investors reported no remaining EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position as of Q4 2021 after selling out during the quarter.
  • Bulldog Investors sold 68,858 EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant shares in Q4 2021, an estimated $689K.
  • Bulldog Investors first reported a position in EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q1 2021 and held it in 3 quarters.
  • Bulldog Investors's EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position peaked at $698K in Q2 2021.
  • 23 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant as of Q4 2021.

Based on Bulldog Investors's 13F filing for Q4 2021, filed 11 Feb 2022.